The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

Title:The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

Volume: 17 Issue: 4

Author(s): Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*

Affiliation:

• Department of Ophthalmology Shiyan, Hubei University of Medicine - Taihe Hospital, Hubei,China

Keywords: Leber's optic hereditary neuropathy, Gene therapy, Translational medicine, Mitochondrial disease, MT-ND4, Allotopic expression technology.

Abstract: Introduction: Leber's Optic Hereditary Neuropathy (LHON) is a common cause of teenaged blindness in both eyes for which there is currently no effective treatment. In 1871, the German ophthalmologist Theodor Leber was the first to describe the clinical characteristics of his namesake disease, and through unremitting efforts over the past 100 years, researchers have continued to increase their understanding of LHON. In recent years, using gene therapy, several groups have obtained breakthroughs in the treatment of the disease.

Conclusion: In this article, we will review the challenging journey that researchers faced towards our current understanding of LHON, and describe the transition of gene therapy research for LHON from the bench to bedside.

Cite this article as:

Zhang Yong , Tian Zhen , Yuan Jiajia , Liu Chang , Liu li Hong , Ma Qi Si and Li Bin *, The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy, Current Gene Therapy 2017; 17 (4) . https://dx.doi.org/10.2174/1566523218666171129204926